Literature DB >> 12047956

Mouse models of prostate carcinogenesis.

Cory Abate-Shen1, Michael M Shen.   

Abstract

In recent years, numerous mouse models have been generated that recapitulate salient features of prostate carcinogenesis in humans. Here we review progress in the generation and validation of mouse models for prostate cancer, discuss current limitations of these models, and highlight directions of future research.

Entities:  

Mesh：

Year:  2002        PMID： 12047956     DOI： 10.1016/s0168-9525(02)02683-5

Source DB:  PubMed          Journal:  Trends Genet        ISSN： 0168-9525            Impact factor:   11.639


  37 in total

1.  Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model.

Authors:  G Wu; Lei Yu; L Wang; H Wang; J W Xuan
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

2.  Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate.

Authors:  David R Shaffer; Agnes Viale; Ryota Ishiwata; Margaret Leversha; Semra Olgac; Katia Manova; Jaya Satagopan; Howard Scher; Andrew Koff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

3.  Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.

Authors:  Uddhav P Kelavkar; Wayne Glasgow; Sandra J Olson; Barbara A Foster; Scott B Shappell
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.

Authors:  Serk In Park; Sun Jin Kim; Laurie K McCauley; Gary E Gallick
Journal:  Curr Protoc Pharmacol       Date:  2010-12

Review 5.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

6.  Characterization of a novel metastatic prostate cancer cell line of LNCaP origin.

Authors:  Mark A Castanares; Ben T Copeland; Wasim H Chowdhury; Minzhi M Liu; Ronald Rodriguez; Martin G Pomper; Shawn E Lupold; Catherine A Foss
Journal:  Prostate       Date:  2015-10-26       Impact factor: 4.104

7.  Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

Authors:  Teresa Chiaverotti; Suzana S Couto; Annemarie Donjacour; Jian-Hua Mao; Hiroki Nagase; Robert D Cardiff; Gerald R Cunha; Allan Balmain
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

8.  Characterization of preclinical models of prostate cancer using PET-based molecular imaging.

Authors:  Sara Belloli; Elena Jachetti; Rosa M Moresco; Maria Picchio; Michela Lecchi; Silvia Valtorta; Massimo Freschi; Rodrigo Hess Michelini; Matteo Bellone; Ferruccio Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-11       Impact factor: 9.236

9.  Sonic Hedgehog pathway activity in prostate cancer.

Authors:  Olga Bragina; Natalja Njunkova; Svetlana Sergejeva; Lilian Järvekülg; Priit Kogerman
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

10.  Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis.

Authors:  Yuqi Cai; David Balli; Vladimir Ustiyan; Logan Fulford; Andrea Hiller; Vinko Misetic; Yufang Zhang; Andrew M Paluch; Susan E Waltz; Susan Kasper; Tanya V Kalin
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.